The selected newsroom has been added to your list of favorites. Go to My Favorites

Our News on Newswise

Newswise: PusztaistudyCancerCellpicFINAL2.jpg

Study Shows Immunotherapy Drug Combination Improves Response in HER2-Negative Breast Cancer Including a Subset of Estrogen Receptor Positive Cancers

In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset...
17-Jun-2021 1:15 PM EDT Add to Favorites

Newswise: HansenJCIInsightstudypic-5.jpg

Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA...
15-Jun-2021 12:05 PM EDT Add to Favorites

Newswise: LuisaEscobar-HoyosMScPhD.jpg

Yale Cancer Center Study Shows Novel Test Can Detect New and Recurrent Bladder Cancer

A study led by researchers at Yale Cancer Center, Stony Brook University and KDx Diagnostics, Inc., examined a revolutionary new urine screening test that utilizes a novel Keratin 17 (K17) cancer biomarker, and revealed the test can detect the...
7-Jun-2021 6:40 PM EDT Add to Favorites

Newswise: NinaKadan-LottickMD.jpeg

Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream...
22-Apr-2021 4:30 PM EDT Add to Favorites

Newswise: MUSCHENPIC2Bigger.jpg

Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL)...
19-Apr-2021 8:00 AM EDT Add to Favorites

Newswise: CONTESSAPIC3Bee.jpg

Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on...
19-Apr-2021 9:00 AM EDT Add to Favorites

Researchers Identify Genes Behind Uterine Leiomyosarcoma Which May Be Treated Using Precision Medicine

In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS).
5-Apr-2021 4:00 PM EDT Add to Favorites

Newswise: CeceliaCalhounMDMSPHMBA2.jpg

Cecelia Calhoun Named Director of the Adolescent-Young Adult Sickle Cell Program at Yale Cancer Center and Smilow Cancer Hospital

Cecelia Calhoun, MD, MSPH, MBA, has been appointed Assistant Professor of Medicine (Hematology) and Assistant Professor of Pediatrics (Hematology/Oncology) at Yale Cancer Center and Smilow Cancer Hospital
23-Mar-2021 2:50 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: MichaelGirardiMDPhD.jpg

Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges

Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT

Newswise: prasanna.jpg

Yale Expert Available to Speak on Medical Marijuana for Children with Cancer

12-Mar-2018 3:05 PM EDT

Newswise: Capture.PNG

Overcoming Resistance to Immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT

Newswise: LiepingChen.JPG

Yale Expert Wins Prestigious 2017 Warren Alpert Prize

6-Oct-2017 2:05 PM EDT

Newswise: CharlesFuchsMDMPHcasual.jpg

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

22-Sep-2017 4:30 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 40 years, Yale Cancer Center is one of only 45 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.

Experts

Contacts

Anne Doerr
Director of Media Relations

anne.doerr@yale.edu

203-737-2629

Renee Gaudette
Director of Marketing & Public Affairs

renee.gaudette@yale.edu

203-671-8156

Scott Gettinger
Associate Professor of Medicine

scott.gettinger@yale.edu

Emily Montemerlo
Marketing Coordinator

emily.fenton@yale.edu

203-785-4343

Twitter

close
1.71158